Leviathan's Drug Problem

John R. Graham

Pacific Research Institute, 07/27/10



This study concludes that allowing American patients to access medicines that have already been approved in Europe would increase regulatory competition, enable more patient choice, and potentially save the lives of those suffering life-threatening illnesses and who currently have no treatment options. Read more...